US Patent Issued to SEQUENOM on Oct. 7 for "Methods and processes for non-invasive analysis of cell-free fetal nucleic acid according to sequence read quantifications for chromosomes 13, 18, and 21" (California Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,437,838, issued on Oct. 7, was assigned to SEQUENOM Inc. (San Diego).

"Methods and processes for non-invasive analysis of cell-free fetal nucleic acid according to sequence read quantifications for chromosomes 13, 18, and 21" was invented by Cosmin Deciu (San Diego) and Zeljko Dzakula (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods, processes and apparatuses for non-invasive assessment of genetic variations."

The patent was filed on Oct. 25, 2019, under Application No. 16/664,265.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=...